In a new letter, published in the Journal of the European Academy of Dermatology and Venereology, members of the lupus ...

Current treatment options for systemic lupus erythematosus (SLE) consists of glucocorticoids, antimalarials, immunosuppressives, and a few biologics, approved or of 'off-label'. Through judicious ...

A new study published in The Journal of the American Heart Association provides insights to improve cardiovascular disease ...

Adding anifrolumab to standard treatment for systemic lupus erythematosus led to faster achievement of low disease activity and remission, and more time spent in those states, vs. standard therapy ...

Just 5% of pediatric providers feel highly confident in evaluating and managing neuropsychiatric SLE in youth.

Fate Therapeutics (NASDAQ:FATE) announced that the U.S. FDA granted Regenerative Medicine Advanced Therapy designation to ...

May 23, 2024 — Treatment of autoimmune diseases like ... Incurable Autoimmune Disease Systemic Lupus Erythematosus (SLE): New Genetic Findings Open Up Perspectives for Future Therapeutic ...

Lupus (systemic lupus erythematosus or SLE) can influence your normal aging process, and your normal aging process likewise can have an effect on your lupus symptoms and your quality of life. What ...

The cell and gene therapy company is cutting 47 employees and its entire lupus program to focus resources on two CAR Ts. The ...

talk with your doctor about the best treatment options for your condition. Saphnelo is a prescription medication used to treat a certain kind of lupus called systemic lupus erythematosus (SLE).

The FDA bestows a Regenerative Medicine Advanced Therapy tag on FATE's pipeline candidate, FT819, for treating moderate-to-severe systemic lupus erythematosus.